Kymriah

The CGTC helps to accelerate clinical trials, training, and research, enabling CHOP to remain a global leader in the space.

In this week’s recap, collaboration at the local and international levels takes center stage.

We usher in Childhood Cancer Awareness Month with headlines that highlight the impact of our cancer breakthroughs.

The last two weeks of 2017 were packed with exciting news for children's health. Catch up in our latest roundup of research headlines.

September marks National Childhood Cancer Awareness Month, and this year at Children's Hospital of Philadelphia, we kick-started the commemorative period on the heels of exciting news about breakthroughs in pediatric cancer immunotherapy research.

It was a pivotal moment that has turned into a new era for cancer immunotherapy. On April 17, 2012, Children's Hospital of Philadelphia researchers for the first time treated a pediatric patient with a cellular therapy that used her own reprogrammed immune cells, called T cells, to attack her aggressive form of blood cancer.